Also, it has been observed that with an increase in the urinary NGAL, there is an increase in the incidence of ischemic atherosclerotic events in patients with CKD, independently of GFR, albuminuria, and other comorbidities [22]. This evidence concerns the gene LCN2 and chronic kidney disease.